(028) 7309 6039
Home
About us
About us
Production Bases
Company Organization Chart
Distribution System
Annual Revenue
Products
Cough Suppressants Expectorants and Mucolytics
Antibiotics
Oral Solid Dosage Form
Injection
Analgesics, Anti-Inflammatory and Antipyretic...
Antihistamines and Combinations
Antiprotozoal Agents
Vaginal Preparations
Antimalarials
Antituberculosis Agents
Infusions
Irrigation Solutions
Creams & Ointments
Tonics and Vitamins
Gastrointestinal Agents
Anthelmintics
Cardiovascular Drugs
Metabolism drugs
Raw Material
Cosmetics
Shareholders
Notice
Dividend
Shareholders
Shareholders Meeting
Share transaction of internal and major shareholders
MKP shares information
Annual Revenue
Financial Revenue
Corporate governance reports
Mekophar information
Leaders
Company rules
Members & relationship
Customer
Recruitment
Contact us
About MEKOPHAR
Shareholders
Products
Contact us
E-mail
Reviewed Interim consolidated financial statements for the first 6 months of 2023
